Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass A - Therapeutic

ESC Medication Library · Revision 3

← Medication library · Compare sanctioning bodies

Albuterol,
Salbutamol

Medication Facts

Performance enhancing
Conditionally if misused
Total hours to clear
72
Frequently used
Most Prescribed
ESC ID
ALBUTE-0027
Trade names
Proventil, Ventolin
Drug type
Beta-2 adrenergic agonist
Plasma half-life · hours
6 hrs nebulizer, 2 hrs IV
Equine dosing
1 to 2 micrograms per kilogram (μg/kg) delivered via an equine mask. For a standard 1,000 lb (450 kg) horse Severe contraindications when combined with Clenbuteral. ***Recently classified by ESC as A1-Therapeutic with 0 WD due to its abiiity to provide health benefits with its short effiicacy.***
Cmax · peak plasma concentration
0.4 ng/mL
Tmax · time to peak plasma concentration
1
ESC concentration guidance
CMAX or 100% of Efficacy
Primary withdrawal · hours
0
Washout withdrawal · hours
48
ESC control type
A1 - Generally Controlled - Therapeutic
Medication report required
Generally not required, however understand exceptions.

Uses & side effects

Promotes Breathing - Relaxes Airway Muscles

Drug interactions

In veterinary medicine, Albuterol (known internationally as Salbutamol) is highly favored for treating equine asthma because it is a short-acting beta-2 agonist. Unlike clenbuterol, it provides immediate, rapid relief from bronchospasms but has a much shorter duration of action.
PubMed

When delivered via inhalation (either through a liquid nebulizer or a metered-dose inhaler [MDI] with an equine spacer mask like the AeroHippus), its pharmacokinetic profile changes drastically compared to systemic administration.

1. Pharmacokinetics: Half-Life, C
max and T max
​
When albuterol is inhaled by a horse, it targets the lungs directly. Only about 19% of the inhaled dose enters systemic blood circulation (bioavailability).
Mad Barn

Terminal Plasma Half-Life: Approximately 6 hours (specifically calculated at 6.06 hours in recent pharmacokinetic profiling). However, its actual clinical bronchodilation effect in the lungs is much shorter, typically lasting between 1 and 3 hours (up to 7 hours max).
ResearchGate

T
max
​
(Time to Peak Concentration): Extremely rapid. Peak concentrations are reached at 0.17 to 0.30 hours (roughly 10 to 18 minutes) after inhalation.
ResearchGate

C
max
​
(Maximum Plasma Concentration): Exceptionally low because the drug acts locally. Following a standard inhaled dose, the peak plasma concentration is just 0.12±0.06 ng/mL.
ResearchGate

Equine Regulatory Note: Because of its potency, the Racing Medication and Testing Consortium (RMTC) heavily regulates albuterol. It has a strict urine threshold of 1.0 ng/mL, which typically requires a 72-hour withdrawal window before a race for standard doses.

2. Standard Equine Dosing Amount
Albuterol is not officially FDA-approved for animals, so veterinarians prescribe human formulations "extra-label."

Metered-Dose Inhaler (MDI): The most common method. The standard dosage is 1 to 2 micrograms per kilogram (μg/kg) delivered via an equine mask. For an average 1,000 lb (450 kg) horse, this equates to roughly 450 to 900 μg per treatment.
Merck Veterinary Manual

Since a standard human inhaler delivers 90 μg per puff, a veterinarian will usually prescribe 5 to 10 puffs administered every 1 to 6 hours as needed for rescue therapy.

Liquid Nebulizer Solution: If using a liquid nebulizer machine, veterinarians often utilize standard human 0.083% or 0.5% solutions, adjusting the volume to deliver an equivalent microgram dose based on the specific machine's delivery efficiency.

3. Critical Drug Interactions
Because albuterol acts heavily on beta-adrenergic receptors, several key drug interactions must be monitored:

Beta-Blockers (e.g., Propranolol, Timolol): These are direct antagonists to albuterol. If a horse is concurrently on a beta-blocker, it will completely block albuterol's ability to dilate the airways, potentially causing severe bronchospasms.

Other Beta-Agonists (e.g., Clenbuterol): Combining albuterol with oral clenbuterol increases the risk of additive cardiovascular side effects, such as dangerous tachycardia (racing heart rate), severe muscle tremors, sweating, and hypokalemia (low potassium).

Diuretics (e.g., Furosemide / "Lasix"): Furosemide is highly common in racing horses to prevent exercise-induced pulmonary hemorrhage (EIPH). Both furosemide and albuterol can lower blood potassium levels. Using them together risks inducing hypokalemia, which can cause muscle weakness or cardiac arrhythmias.

Tricyclic Antidepressants or MAOIs: Though rarely used in horses, concurrent use can wildly potentiate albuterol's effects on the vascular system, resulting in severe cardiovascular stress.

Contraindications

Clenbuteral, Albuterol, Salbutamol, Ventipulmen, Tri-Hist, Dexamethasone

Government Numbers

Ventolin HFA: human prescription product, NDA 020983. NDC 0173-0682-20 (200 inhalations) and 0173-0682-24 (60 inhalations). Labeler: GlaxoSmithKline LLC. These identifiers do not establish equine approval or an equine dose. Reviewed September 18, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d92c5d6b-ff10-4087-36a2-1cfc464cb967

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

VIO401.5, .6, .8

Reviewed 2026-09-23

No permitted competition dosing regimen.No permitted plasma threshold stated.No permitted-use withdrawal allowance established here.Explicitly prohibited.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

The schedule’s non-plasma guidance is excluded from this comparison. Prohibited for Quarter Horse racing; no applicable withdrawal allowance for that scope. NOTE: "A" penalty for quarter horse races. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

CTMS 4.2.1; UCG 20.0 PDF p. 11

Reviewed 2026-09-23

No plasma-linked dosing guidance in the cited schedule.No plasma threshold published in CTMS 4.2.1.No plasma-linked withdrawal guideline shown.Drug Class 3 · Penalty Class B. See ARCI drug and penalty classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.